[3] When available, continuous glucose monitoring metrics such as time-in-range can provide valuable data to guide dose adjustment decisions
The cysteine modification is expected to trigger a conformational change of the Keap1 homodimer, which could dissociate the weak binding site, the DLG motif (latch), from the Keap1 DC domain, while the strong binding site, the ETGE motif (hinge), remains attached to the other Keap1 DC domain
You may need a different treatment Ozempic gets a lot of attention, but its not the only option for weight loss and its not even FDA-approved specifically for that use
And the dose-dependent effects were clear: 4 mg, 8 mg, and 12 mg doses all produced escalating weight loss, with the highest dose delivering the most dramatic results